SAN DIEGO, April 19, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences (“Apricus Bio”) (Nasdaq:APRI) (http://www.apricusbio.com/index.html) is building a strong product pipeline backed by a sound financial position, Chairman, President and Chief Executive Officer, Dr. Bassam Damaj, told CEO/CFO Magazine in a recent interview. The complete interview is available here: http://ceocfointerviews.com/interviews/APRI-Apricus11.htm.
